Information de reference pour ce titreAccession Number: | 00004678-200411000-00016.
|
Author: | Armas, Laura A. G.; Hollis, Bruce W.; Heaney, Robert P.
|
Institution: | Creighton University (L.A.G.A., R.P.H.), Omaha, Nebraska 68131; and Medical University of South Carolina (B.W.H.), Charleston, South Carolina 29425
|
Title: | |
Source: | Journal of Clinical Endocrinology & Metabolism. 89(11):5387-5391, November 2004.
|
Abstract: | Vitamins D2 and D3 are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D2) available in the U.S. market.
The relative potencies of vitamins D2 and D3 were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline.
The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D3-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D2-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng[middle dot]d/ml (150.5 nmol[middle dot]d/liter) for vitamin D2 and 204.7 (511.8) for vitamin D3 (P < 0.002). Calculated AUC[infinity] indicated an even greater differential, with the relative potencies for D3:D2 being 9.5:1.
Vitamin D2 potency is less than one third that of vitamin D3. Physicians resorting to use of vitamin D2 should be aware of its markedly lower potency and shorter duration of action relative to vitamin D3.
Copyright (C) 2004 by The Endocrine Society
|
References: | 1. Vieth R 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-856
2. Utiger RD 1998 The need for more vitamin D. N Engl J Med 338:828-829
3. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ 2003 Human serum 25-hydroxy-cholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210
4. MacLaughlin J, Holick MF 1985 Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536-1538
5. Parfitt AM 1990 Osteomalacia and related disorders. In: Avioli LV, Krane SM, eds. Metabolic bone disease and clinically related disorders. 2nd ed. Philadelphia: WB Saunders; 329-396
6. Trivedi DP, Doll R, Khaw KT 2003 Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469-474
7. Food and Nutrition Board, Institute of Medicine 1997 Dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride. Washington, DC: National Academy Press
8. Tjellesen L, Hummer L, Christiansen C, Rodbro P 1986 Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1:407-413
9. Trang H, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R 1998 Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68:854-858
10. Koutkia P, Lu Z, Chen TC, Holick MF 2001 Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 121:1485-1488
11. Hollis BW 1997 Detection of vitamin D and its major metabolites. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego: Academic Press; 587-606
12. Hollis BW 2000 Comparison of commercially available 125I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46:1657-1661
13. Nilsson SF, Ostberg L, Peterson PA 1972 Binding of vitamin D to its human carrier plasma protein. Biochem Biophys Res Commun 46:1380-1387
14. Hollis BW, Frank NE 1986 Quantitation of vitamin D2, vitamin D3, 25-hydroxyvitamin D2, and 25-hydroxyvitamin D3 in human milk. Methods Enzymol 123:167-176
15. Hollis BW 1984 Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem 21:81-86
16. Baird DP, Hordon R, Longcope C, Tait JF 1969 Steroid hormone dynamics under steady state conditions. Recent Prog Horm Res 25:611-664
17. Haddad JG, Matsuoka LT, Hollis BW, Hu YZ, Wortsman J 1993 Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91:2552-2555
18. Hoy DA, Ramberg CF, Horst RL 1988 Evidence that discrimination against ergocalciferol by the chick is the result of enhanced metabolic clearance rates or its mono- and di-hydroxylated metabolites. J Nutr 118:633-638
19. Heaney RP, Dowell MS, Hale CA, Bendich A 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142-146
20. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelman M 2003 Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351
21. Bischoff HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B 2004 Higher 25-hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged >= 60 y. Am J Clin Nutr 80:752-758
22. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R 2004 Vitamin D round table. In: Burckhardt P, Dawson-Hughes B, Heaney RP, eds. Nutritional aspects of osteoporosis. 2nd ed. San Diego: Elsevier; 263-270
23. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783
24. Plotnikoff GA, Quigley JM 2003 Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78:1463-1470
25. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A 2004 Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60-65
26. Grant WB 2002 An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867-1875
27. Hollis B 2004 Determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 89:3149-3151 (Editorial)
28. Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Kokko AM, Kolho LA, Rajala SA 1992 Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105-110
29. Chevalley T, Rizzoli R, Nydegger V, Slosman D, Rapin CH, Michel JP, Vasey H, Bonjour JP 1994 Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 4:245-252
|
Language: | English.
|
Document Type: | Endocrine Care: Of Special Interest to the Practice of Endocrinology.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0021-972X
|
NLM Journal Code: | hrb, 0375362
|
Annotation(s) | |
|
|